Welcome to Glythera
Glythera Limited is a biotechnology company specializing in the development of enhanced protein/peptide therapeutics through the use of advanced glycosylation and conjugation technologies. Originally spun-out from the University of Bath, the Company relocated to the Newcastle-upon-Tyne INEX incubator facility in 2012, following investment from the IP Group and the Finance for Business North East Technology Fund. Gylthera's core technologies - Permalink™ and Permacarb™ - allow the selective and stable functionalization and glycosylation of biopharmaceuticals for improved stability, bioavailability and efficacy.
Sign up to our mailing list
Simply enter your email address below to receive all of our latest news direct to your inbox.